We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNKO icon
6126
CALL
Funko
FNKO
$341M
$1.43M ﹤0.01%
63,900
+12,100
+23% +$234K
NOBL icon
6127
CALL
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$1.43M ﹤0.01%
+33,400
New +$1.52M
TASK icon
6128
CALL
TaskUs
TASK
$659M
$1.43M ﹤0.01%
84,600
-127,800
-60% -$3.26M
NTCT icon
6129
CALL
NETSCOUT
NTCT
$2.85B
$1.43M ﹤0.01%
42,100
+29,500
+234% +$990K
REPL icon
6130
CALL
Replimune Group
REPL
$1.37B
$1.43M ﹤0.01%
81,500
+68,600
+532% +$1.13M
VMBS icon
6131
PUT
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$1.43M ﹤0.01%
+29,800
New +$1.44M
ROG icon
6132
Rogers Corp
ROG
$2.61B
$1.42M ﹤0.01%
5,432
-7,086
-57% -$1.88M
CCS icon
6133
PUT
Century Communities
CCS
$2B
$1.42M ﹤0.01%
31,600
-1,700
-5% -$85.9K
EWH icon
6134
CALL
iShares MSCI Hong Kong ETF
EWH
$1.23B
$1.42M ﹤0.01%
64,000
-28,300
-31% -$614K
NFG icon
6135
CALL
National Fuel Gas
NFG
$7.78B
$1.42M ﹤0.01%
21,500
+9,900
+85% +$694K
NRIX icon
6136
CALL
Nurix Therapeutics
NRIX
$2.82B
$1.42M ﹤0.01%
112,100
+25,000
+29% +$283K
CASS icon
6137
Cass Information Systems
CASS
$733M
$1.42M ﹤0.01%
41,977
-2,212
-5% -$79.4K
TAK icon
6138
PUT
Takeda Pharmaceutical
TAK
$55.5B
$1.42M ﹤0.01%
101,100
-35,400
-26% -$505K
ONEM
6139
CALL
DELISTED
1Life Healthcare
ONEM
$1.42M ﹤0.01%
181,000
+68,700
+61% +$590K
IWP icon
6140
PUT
iShares Russell Mid-Cap Growth ETF
IWP
$21.2B
$1.42M ﹤0.01%
17,900
-80,800
-82% -$7.04M
ROCK icon
6141
CALL
Gibraltar Industries
ROCK
$1.41B
$1.42M ﹤0.01%
36,600
+7,000
+24% +$286K
JLL icon
6142
PUT
Jones Lang LaSalle
JLL
$17B
$1.42M ﹤0.01%
8,100
+500
+7% +$99.7K
MFUS icon
6143
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$305M
$1.42M ﹤0.01%
+39,123
New +$1.53M
PFG icon
6144
CALL
Principal Financial Group
PFG
$24.2B
$1.42M ﹤0.01%
21,200
+3,600
+20% +$253K
TXG icon
6145
CALL
10x Genomics
TXG
$7.56B
$1.42M ﹤0.01%
31,300
-35,300
-53% -$1.83M
CNTA
6146
DELISTED
Centessa Pharmaceuticals
CNTA
$1.42M ﹤0.01%
290,583
-13,843
-5% -$88.6K
NG icon
6147
NovaGold Resources
NG
$3.4B
$1.42M ﹤0.01%
294,278
-258,701
-47% -$1.62M
TSLX icon
6148
CALL
Sixth Street Specialty
TSLX
$1.75B
$1.41M ﹤0.01%
76,400
+31,900
+72% +$675K
AQB icon
6149
CALL
AquaBounty Technologies
AQB
$7.21M
$1.41M ﹤0.01%
41,275
+37,690
+1,051% +$1.15M
BCML icon
6150
BayCom
BCML
$334M
$1.41M ﹤0.01%
68,304
+51,369
+303% +$1.13M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.